P rostate-specific antigen (PSA) is a protein made by the prostate gland. A high PSA level could be a sign of an enlarged prostate, inflammation called prostatitis, or prostate cancer. The PSA test ...

Dye binds to proteins altered by prostate cancer fo form PSA. Two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

NEW YORK (Reuters Health) - Men with long-term diabetes may have a reduced risk of prostate cancer, according to the results of a study published in the American Journal of Epidemiology. "Recent ...

Dr. Wallen: PSA can vary even day by day in patients for a lot of reasons. First of all, PSA is not a cancer specific test.

Men living in US counties with a higher prevalence of PSA screening are less likely to have advanced prostate cancer and to die from it. In the United States, access to county-based PSA screening is ...

PET can guide intensified salvage therapy in prostate cancer and help reduce the risk for treatment failure, new research suggests.

Screening with the prostate-specific antigen (PSA) test can detect early-stage prostate cancer while it’s still asymptomatic.